Literature DB >> 15283771

Exploring type I angiotensin (AT1) receptor functions through gene targeting.

S D Crowley1, P-L Tharaux, L P Audoly, T M Coffman.   

Abstract

The renin-angiotensin system (RAS) modulates a diverse set of physiological processes including development, blood pressure, renal function and inflammation. The principal effector molecule of this system, angiotensin II, mediates most of these actions. The classically recognized functions of the RAS are triggered via the type 1 (AT(1)) class of angiotensin receptors. Pharmacological blockade of the AT(1) receptor lowers blood pressure and slows the progression of cardiovascular and renal diseases. Gene-targeting technology provides an experimental approach for precisely dissecting the physiological functions of the RAS. Here, we review how gene-targeting experiments have elucidated AT(1) receptor functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15283771     DOI: 10.1111/j.1365-201X.2004.01331.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  21 in total

Review 1.  Is RAS blockade routinely indicated in hypertensive kidney transplant patients?

Authors:  Daniel J Salzberg
Journal:  Curr Hypertens Rep       Date:  2007-11       Impact factor: 5.369

Review 2.  Atherosclerotic renal artery stenosis: current status.

Authors:  Soon Hyo Kwon; Lilach O Lerman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

3.  Age-related hypertension and salt sensitivity are associated with unique cortico-medullary distribution of D1R, AT1R, and NADPH-oxidase in FBN rats.

Authors:  Indira Pokkunuri; Gaurav Chugh; Imran Rizvi; Mohammad Asghar
Journal:  Clin Exp Hypertens       Date:  2015-01-06       Impact factor: 1.749

Review 4.  Salt, Hypertension, and Immunity.

Authors:  A Justin Rucker; Nathan P Rudemiller; Steven D Crowley
Journal:  Annu Rev Physiol       Date:  2017-11-16       Impact factor: 19.318

5.  A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension.

Authors:  Steven D Crowley; Young-Soo Song; Gregory Sprung; Robert Griffiths; Matthew Sparks; Ming Yan; James L Burchette; David N Howell; Eugene E Lin; Benson Okeiyi; Johannes Stegbauer; Yanqiang Yang; Pierre-Louis Tharaux; Phillip Ruiz
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

6.  Lymphocyte responses exacerbate angiotensin II-dependent hypertension.

Authors:  Steven D Crowley; Young-Soo Song; Eugene E Lin; Robert Griffiths; Hyung-Suk Kim; Phillip Ruiz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

7.  The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases.

Authors:  Jiandong Zhang; Steven D Crowley
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 8.  Renal dopamine and angiotensin II receptor signaling in age-related hypertension.

Authors:  Gaurav Chugh; Indira Pokkunuri; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24

9.  Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis.

Authors:  Steven D Crowley; Matthew P Vasievich; Phillip Ruiz; Samantha K Gould; Kelly K Parsons; A Kathy Pazmino; Carie Facemire; Benny J Chen; Hyung-Suk Kim; Trinh T Tran; David S Pisetsky; Laura Barisoni; Minolfa C Prieto-Carrasquero; Marie Jeansson; Mary H Foster; Thomas M Coffman
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

10.  Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.

Authors:  Steven D Crowley; Campbell W Frey; Samantha K Gould; Robert Griffiths; Phillip Ruiz; James L Burchette; David N Howell; Natalia Makhanova; Ming Yan; Hyung-Suk Kim; Pierre-Louis Tharaux; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.